Pipeline cuts for Sanofi; Breakthru Medicine raises $60Mnews2026-01-29T15:42:15+00:00January 29th, 2026|Endpoints News|
Summit gets November PDUFA date for its PD-1xVEGF bispecificnews2026-01-29T15:07:25+00:00January 29th, 2026|Endpoints News|
Trump looks to raise South Korea levies; Siegfried expandsnews2026-01-29T14:42:20+00:00January 29th, 2026|Endpoints News|
Agomab anticipates $182M IPO as it builds fibrosis pipelinenews2026-01-29T14:13:32+00:00January 29th, 2026|Endpoints News|
AstraZeneca makes $15B bet on China to expand manufacturing and R&Dnews2026-01-29T13:39:17+00:00January 29th, 2026|Endpoints News|
Premise Health to merge with Crossover Health to expand employer clinicsnews2026-01-29T13:00:02+00:00January 29th, 2026|Endpoints News|
Updated: Roche predicts its breast cancer pill could become its biggest-selling drugnews2026-01-29T12:11:54+00:00January 29th, 2026|Endpoints News|
Following Abivax, Formation Bio licenses miR-124 drug from Chinanews2026-01-29T12:00:49+00:00January 29th, 2026|Endpoints News|
Sanofi says its €15B dealmaking budget, R&D spend should help ease looming Dupixent patent cliffnews2026-01-29T11:46:10+00:00January 29th, 2026|Endpoints News|
Flagship’s Repertoire gets another autoimmune partner in Lillynews2026-01-29T11:30:20+00:00January 29th, 2026|Endpoints News|
